Breaking US Plans Significant Spending Increase to Counter China’s Global Influence Bryan Kohberger Seeks to Withdraw Guilty Plea, Cites Coercion by Attorneys Kamala Harris Endorses Troy Jackson in Key Maine Senate Race Former Olympian David Hearn Seeks Access to Grand Jury Testimony in Lincoln Memorial Pool Damage Case Weill Cornell Medicine Reaches Agreement to End Federal Criminal Investigation

Monday July 27, 2026

Reporter

Eli Lilly and Company

2Articles Published

5Communities Covered

Published Articles

Press Release

Lilly’s triple agonist, retatrutide, successful in two additional Phase 3 obesity trials, delivering significant improvements in weight and A1C

Jul 23

Press Release

Lilly confirms date and conference call for second-quarter 2026 financial results announcement

Jul 22